- Issuer
- Tema
- Inception Date
- Aug 14, 2023
- Region
- Global (Broad)
- Category
- Health & Biotech Equities
- Leveraged
- 1x (No leverage)
- Index Tracked
- No Index (Active)
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Mid-Cap
- Asset Class Style
- Growth
- Assets Under Management
- $194M
Highlights
- Avg. Volume (1M)
- 32K
- Avg. Volume Value (1M)
- $1.31M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
CANC Performance Chart
Tema Oncology ETF (CANC) is up 16.9% since the beginning of the year. CANC is currently trading at $41 per share.
Loading charts...
Compare this symbol against anything
Returns By Period
Tema Oncology ETF (CANC) has returned 16.92% so far this year and 56.68% over the past 12 months.
Tema Oncology ETF
- 1D
- -1.72%
- 1M
- -2.95%
- 6M
- 13.52%
- YTD
- 16.92%
- 1Y
- 56.68%
- 3Y*
- 102.33%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -9.07%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
CANC Monthly Returns History
Based on dividend-adjusted daily data since Sep 30, 2021, CANC's average daily return is +0.36%, while the average monthly return is +4.41%. At this rate, an investment would double in approximately 1.3 years.
Historically, 46% of months were positive and 54% were negative. The best month was Aug 2023 with a return of +380.4%, while the worst month was Nov 2021 at -42.0%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 7 months.
On a daily basis, CANC closed higher 48% of trading days. The best single day was Aug 15, 2023 with a return of +588.9%, while the worst single day was Apr 1, 2022 at -21.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 2.99% | 5.66% | -2.88% | 2.21% | 1.56% | 8.26% | -1.56% | 16.92% | |||||
| 2025 | 5.69% | -0.20% | -6.08% | 3.69% | -2.76% | 1.83% | 4.76% | 2.87% | 7.72% | 7.94% | 15.38% | -2.81% | 42.92% |
| 2024 | -0.94% | 7.88% | -0.33% | -5.51% | 0.68% | 0.86% | 8.86% | 1.70% | -4.89% | -2.78% | 0.73% | -10.22% | -5.37% |
| 2023 | 20.87% | -28.03% | -27.43% | -15.51% | 75.43% | -7.62% | 38.83% | 380.39% | -7.60% | -5.01% | 9.18% | 10.52% | 510.51% |
| 2022 | -13.75% | 2.19% | -12.54% | -33.57% | -14.21% | -28.22% | -26.84% | -0.19% | -26.95% | 3.02% | -6.69% | -9.38% | -85.34% |
| 2021 | -7.34% | -4.55% | -42.04% | -12.91% | -55.35% |
Benchmark Metrics
Tema Oncology ETF has an annualized alpha of 134.91%, beta of 0.45, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since September 30, 2021.
- This ETF participated in 110.81% of S&P 500 Index downside but only 30.51% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.45 may look defensive, but with R2 of 0.00 this ETF is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this ETF's risk.
- R2 of 0.00 means this ETF moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 134.91%
- Beta
- 0.45
- R²
- 0.00
- Upside Capture
- 30.51%
- Downside Capture
- 110.81%
Expense Ratio
CANC has an expense ratio of 0.75%, placing it in the medium range.
Return for Risk
Risk / Return Rank
CANC ranks 92 for risk / return — above 92% of ETFs peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Tema Oncology ETF (CANC) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CANC | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.10 | ||
| Sortino ratioReturn per unit of downside risk | +1.54 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 1.25 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 6.14 | 2.00 | +4.14 |
| Martin ratioReturn relative to average drawdown | 16.53 | 8.49 | +8.04 |
Dividends
Dividend History
Tema Oncology ETF provided a 0.05% dividend yield over the last twelve months, with an annual payout of $0.02 per share.
| Period | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Dividend | $0.02 | $0.02 | $0.73 | $0.15 |
Dividend yield | 0.05% | 0.06% | 3.00% | 0.56% |
Monthly Dividends
The table displays the monthly dividend distributions for Tema Oncology ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.02 | $0.02 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.73 | $0.73 |
| 2023 | $0.15 | $0.15 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Tema Oncology ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Tema Oncology ETF was 97.53%, occurring on Apr 5, 2023. The portfolio has not yet recovered.
The current Tema Oncology ETF drawdown is 51.53%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-97.53%Apr 2023 | 1y 5mo | — | 4y 9moOct 2021 - now | — |
-16.18%Oct 2021 | 13d | 1d | 14dOct 2021 - Oct 2021 | — |
-7.34%Sep 2021 | 1d | 5d | 5dSep 2021 - Oct 2021 | — |
Drawdown Indicators
| CANC | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.53% | -56.78% | -40.75% |
Max Drawdown (1Y)Largest decline over 1 year | -9.30% | -9.10% | -0.20% |
Max Drawdown (3Y)Largest decline over 3 years | -28.04% | -18.90% | -9.14% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -51.53% | -1.58% | -49.95% |
Average DrawdownAverage peak-to-trough decline | -72.46% | -10.70% | -61.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.45% | 2.14% | +1.31% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with CANC
Add Tema Oncology ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with CANC